SlideShare a Scribd company logo
14
Describing the Performance
of a Diagnostic Test
[Q: Write shorts notes on: Performance of diagnostic test
(BSMMU, January, 2009)]
Types of diagnostic tests
1. Qualitative diagnostic tests classify patients as diseased
or disease-free according to the presence or absence of a
clinical sign or symptom. For example, an x-ray might
confirm or disprove the existence of a fracture.
2. Quantitative diagnostic tests classify patients as diseased
or disease-free on the basis of whether they fall above or
Biostatistics-139
below a reselected cutoff value known as the positivity
criterion. This cutoff value is also referred to as the critical
value or referent value.
Test performance characteristics
[Q:
 Define 'specify' and 'sensitivity' with example. (BSMMU,
Radiology, January, 2012)
 What do you mean by "sensitively" and "specificity". Give
example for each of them. (BSMMU, July, 2010)
 Discuss the statistical tools used to assess the performance of
a diagnosis test. (BSMMU, January, 2011)]
1. Sensitivity
Definition: Chance of having a positive test in patients with
the test condition
Calculating sensitivity: Sensitivity is calculated as the
proportion of diseased individuals with a positive test result,
using the formula
diseased with positive test
sensitivity = all diseased
Example: Of the 600 individuals with breast cancer as
determined by biopsy 570 had a positive result on the BCPF
test. Thus,
sensitivity = = 570/600 = .95
A high sensitivity implies few false negatives which is important
for very rare or lethal diseases, e.g. phenylketonuria.
2. Specificity
Biostatistics-140
Definition. Chance of having a negative test in patients
without the condition
Calculating specificity: Specificity is calculated as the
proportion of disease-free individuals with a negative test
result, using the formula
disease-free with negative test
specificity = all disease-free
Example: Of the 1000 individuals without breast cancer as
determined by biopsy 850 had a negative result on the BCPF
test. Thus,
specificity = 850/1000 = .85
A high specificity implies few false positives, which is important
for common diseases, e.g. diabetes.
3. False negative rate
a. Definition. The false negative rate (FNR) of a diagnostic test
is the probability that a diseased individual will have a negative
test result.
c. Calculation. FNR is calculated as the proportion of diseased
individuals with a negative test result, using the formula
diseased with negative test
all diseased
FNR=
4. False positive rate
a. Definition: The false positive rate(FPR) of a diagnostic test is
the probability that a diseases free individual will have a
positive result.
Biostatistics-141
Calculation: FPR is the calculated as the proportion of diseases
free individual with a positive result using the formula
diseases free with a positive test
all disease free
FPR=
Example: Of the 1000 individuals who did not have breast
cancer , 150 had positive result on the BCPF test, thus
FPR=150/1000=1.5
5. Predictive value
This is the proportion of positive test results that are truly
positive.
True positive (a) x 100
True positive (a) + false positive (b)
Accuracy
The proportion of all tests those are correct.
The accuracy of a laboratory test is its correspondence with the
true value. An inaccurate test is one that differs from the true
value even though the results may be reproducible. In the
clinical laboratory, accuracy of tests is maximized by calibrating
laboratory equipment with reference material and by
participation in external quality control programs.
Precision
Test precision is a measure of a test’s reproducibility when
repeated on the same sample. An imprecise test is one that
yields widely varying results on repeated measurements.
Validity
The extent to which a test measures what it is supposed to
measure. Sensitivity and specificity are two important
components of validity.
Biostatistics-142
Reliability
The extent to which a test yields consistent results and thus is
replicable
Comparison of a survey test with a reference test
Table: Comparison of a survey test with a reference test
Survey
test result
Reference test result Totals
Positive Negative
Positive True positives,
correctly
identified = (a)
False positives =
(b)
Total test
positives =
(a + b)
Negative False negatives
= (c)
True negatives
correctly
identified = (d)
Total test
negatives =
(c + d)
Totals Total true
positives =
(a + c)
Total true
negatives =
(b + d)
Grand total
=
(a + b + c +
Valid and reliable
Biostatistics-143
d)
From this table four important statistics can be derived:
Sensitivity = a/ (a + c).
Specificity = d/ (b + d).
Accuracy = (a+d)/(a+b+c+d)
Likelihood ratio
The likelihood ratio for a particular value of a diagnostic test is
defined as: the probability of that test result in the presence of a
disease, divided by the probability of the result in people without
the disease.
Likelihood ratios express how many times more (or less) likely a
test result is to be found in diseased as compared to non-
diseased people.
Reproducibility
It is the variability of repeated measurements under different
conditions.
[Q:
 Out of 1000 suspected lung cancer patients, 800 found to have
the disease diagnosed by CT scan. Among those, 320 patients
were found FNAC positive and the total FNAC positive were
322. Evaluate the performance of FNAC in the diagnosis of
lung cancer. (BSMMU, Radiology, January, 2012)
 USG negative cases respectively. Will you advocate USG for
diagnosis of hepatoma? (BSMMU, July, 2011)
 1000 suspected brain tumor patients were subjected to CT
scan & MRI. Based on MRI 200 diagnosed as brain tumor of
which 156 were CT positive out of total 420 CT Positive cases.
Evaluate the performance of CT scan of diagnosis of brain
tumor. (BSMMU, January, 2011)
 317 suspected cases of heptoma were subjected to FNAC and
CT scan. FNAC confirmed hepatoma in 113 and 08 cases out
of 128 CT positive & 189 CT negative cases respectively.
Evaluate the performance of CT scan in diagnosis of
hepatoma. (BSMMU, July, 2010)
Biostatistics-144
 370 suspected cases of prostate cancer were investigated by
CT scan and serum PSA. CT scan confirmed prostate cancer in
113 and 8 cases out of 8 cases out of 178 PSA positive and 192
PSA negative cases receptivity. Will you advocate PSA
measurement in diagnosis of prostate cancer? (BSMMU,
January, 2009)]

More Related Content

Similar to Ch 14 diagn test.doc

CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
CAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptxCAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptx
CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
Shafici Almis
 
Validity and realibility.pptx
Validity and realibility.pptxValidity and realibility.pptx
Validity and realibility.pptx
briankash1
 
Screening of diseases
Screening of diseasesScreening of diseases
Screening of diseases
PrateekGoyal67
 
Disease screening
Disease screeningDisease screening
Disease screening
Amandeep Kaur
 
unit 1. Introduction to CLM.pptx
unit  1. Introduction to CLM.pptxunit  1. Introduction to CLM.pptx
unit 1. Introduction to CLM.pptx
reshadnuredin1
 
screening and diagnostic testing
screening and diagnostic  testingscreening and diagnostic  testing
screening and diagnostic testing
amitakashyap1
 
Screening and diagnostic tests
Screening and diagnostic testsScreening and diagnostic tests
Screening and diagnostic tests
Bharat Paul
 
How to write your radiology report
How to write  your radiology reportHow to write  your radiology report
How to write your radiology report
Mahmoud Tawfik
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
Nilesh Kucha
 
screening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptxscreening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptx
LeHaRe
 
Disease screening and screening test validity
Disease screening and screening test validityDisease screening and screening test validity
Disease screening and screening test validity
TampiwaChebani
 
chapter2-191105204556.pdf
chapter2-191105204556.pdfchapter2-191105204556.pdf
chapter2-191105204556.pdf
Soujannya Kundu Chowdhury
 
Diagnostic test
Diagnostic test Diagnostic test
Diagnostic test
Zafar Equebal
 
Validity and Screening Test
Validity and Screening TestValidity and Screening Test
Validity and Screening Test
Dr. Abraham Mallela
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
SakhileKhoza2
 
Evidence-Based Medicine Glossary
Evidence-Based Medicine GlossaryEvidence-Based Medicine Glossary
Evidence-Based Medicine Glossary
Dr. Faisal Al Haddad
 
Diagnotic and screening tests
Diagnotic and screening testsDiagnotic and screening tests
Diagnotic and screening tests
jfwilson2
 
Dr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshareDr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshare
International Islamic University Malaysia
 
Screening for disease.ppt
Screening for disease.pptScreening for disease.ppt
Screening for disease.ppt
rambhapathak
 

Similar to Ch 14 diagn test.doc (20)

CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
CAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptxCAT 1 -MPH 5101 -  FOUNDATIONS OF EPIDEMIOLOGY  (1).pptx
CAT 1 -MPH 5101 - FOUNDATIONS OF EPIDEMIOLOGY (1).pptx
 
Validity and realibility.pptx
Validity and realibility.pptxValidity and realibility.pptx
Validity and realibility.pptx
 
Screening of diseases
Screening of diseasesScreening of diseases
Screening of diseases
 
Disease screening
Disease screeningDisease screening
Disease screening
 
unit 1. Introduction to CLM.pptx
unit  1. Introduction to CLM.pptxunit  1. Introduction to CLM.pptx
unit 1. Introduction to CLM.pptx
 
screening and diagnostic testing
screening and diagnostic  testingscreening and diagnostic  testing
screening and diagnostic testing
 
Screening and diagnostic tests
Screening and diagnostic testsScreening and diagnostic tests
Screening and diagnostic tests
 
How to write your radiology report
How to write  your radiology reportHow to write  your radiology report
How to write your radiology report
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
screening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptxscreening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptx
 
Disease screening and screening test validity
Disease screening and screening test validityDisease screening and screening test validity
Disease screening and screening test validity
 
chapter2-191105204556.pdf
chapter2-191105204556.pdfchapter2-191105204556.pdf
chapter2-191105204556.pdf
 
Diagnostic test
Diagnostic test Diagnostic test
Diagnostic test
 
Validity and Screening Test
Validity and Screening TestValidity and Screening Test
Validity and Screening Test
 
Clinical epidemiology
Clinical epidemiologyClinical epidemiology
Clinical epidemiology
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
 
Evidence-Based Medicine Glossary
Evidence-Based Medicine GlossaryEvidence-Based Medicine Glossary
Evidence-Based Medicine Glossary
 
Diagnotic and screening tests
Diagnotic and screening testsDiagnotic and screening tests
Diagnotic and screening tests
 
Dr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshareDr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshare
 
Screening for disease.ppt
Screening for disease.pptScreening for disease.ppt
Screening for disease.ppt
 

More from AbedurRahman5

Ch 17 Risk Ratio.doc
Ch 17 Risk Ratio.docCh 17 Risk Ratio.doc
Ch 17 Risk Ratio.doc
AbedurRahman5
 
Ch 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..docCh 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..doc
AbedurRahman5
 
ch 13 Correlation and regression.doc
ch 13 Correlation  and regression.docch 13 Correlation  and regression.doc
ch 13 Correlation and regression.doc
AbedurRahman5
 
Ch 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.docCh 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.doc
AbedurRahman5
 
ch 9 Confidence interval.doc
ch 9 Confidence interval.docch 9 Confidence interval.doc
ch 9 Confidence interval.doc
AbedurRahman5
 
Ch 8 NORMAL DIST..doc
Ch 8 NORMAL DIST..docCh 8 NORMAL DIST..doc
Ch 8 NORMAL DIST..doc
AbedurRahman5
 
ch 7 Tertile, Quartile, and Percentile.doc
ch 7 Tertile, Quartile, and Percentile.docch 7 Tertile, Quartile, and Percentile.doc
ch 7 Tertile, Quartile, and Percentile.doc
AbedurRahman5
 
Ch 6 DISPERSION.doc
Ch 6 DISPERSION.docCh 6 DISPERSION.doc
Ch 6 DISPERSION.doc
AbedurRahman5
 
Ch 5 CENTRAL TENDENCY.doc
Ch 5 CENTRAL TENDENCY.docCh 5 CENTRAL TENDENCY.doc
Ch 5 CENTRAL TENDENCY.doc
AbedurRahman5
 
Ch 4 SAMPLE..doc
Ch 4 SAMPLE..docCh 4 SAMPLE..doc
Ch 4 SAMPLE..doc
AbedurRahman5
 
Ch 3 DATA.doc
Ch 3 DATA.docCh 3 DATA.doc
Ch 3 DATA.doc
AbedurRahman5
 
Ch 2 Variables.doc
Ch 2 Variables.docCh 2 Variables.doc
Ch 2 Variables.doc
AbedurRahman5
 
Ch 1 Introduction..doc
Ch 1 Introduction..docCh 1 Introduction..doc
Ch 1 Introduction..doc
AbedurRahman5
 
ch 18 roc.doc
ch 18  roc.docch 18  roc.doc
ch 18 roc.doc
AbedurRahman5
 
ch 2 hypothesis
ch 2 hypothesisch 2 hypothesis
ch 2 hypothesis
AbedurRahman5
 
Questionnaire Design
Questionnaire Design Questionnaire Design
Questionnaire Design
AbedurRahman5
 
Research
 Research  Research
Research
AbedurRahman5
 
Study design
Study design Study design
Study design
AbedurRahman5
 
Biotechnology and Genetic Engineering
Biotechnology and Genetic EngineeringBiotechnology and Genetic Engineering
Biotechnology and Genetic Engineering
AbedurRahman5
 

More from AbedurRahman5 (19)

Ch 17 Risk Ratio.doc
Ch 17 Risk Ratio.docCh 17 Risk Ratio.doc
Ch 17 Risk Ratio.doc
 
Ch 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..docCh 15 Measures of morbidity..doc
Ch 15 Measures of morbidity..doc
 
ch 13 Correlation and regression.doc
ch 13 Correlation  and regression.docch 13 Correlation  and regression.doc
ch 13 Correlation and regression.doc
 
Ch 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.docCh 12 SIGNIFICANT TESTrr.doc
Ch 12 SIGNIFICANT TESTrr.doc
 
ch 9 Confidence interval.doc
ch 9 Confidence interval.docch 9 Confidence interval.doc
ch 9 Confidence interval.doc
 
Ch 8 NORMAL DIST..doc
Ch 8 NORMAL DIST..docCh 8 NORMAL DIST..doc
Ch 8 NORMAL DIST..doc
 
ch 7 Tertile, Quartile, and Percentile.doc
ch 7 Tertile, Quartile, and Percentile.docch 7 Tertile, Quartile, and Percentile.doc
ch 7 Tertile, Quartile, and Percentile.doc
 
Ch 6 DISPERSION.doc
Ch 6 DISPERSION.docCh 6 DISPERSION.doc
Ch 6 DISPERSION.doc
 
Ch 5 CENTRAL TENDENCY.doc
Ch 5 CENTRAL TENDENCY.docCh 5 CENTRAL TENDENCY.doc
Ch 5 CENTRAL TENDENCY.doc
 
Ch 4 SAMPLE..doc
Ch 4 SAMPLE..docCh 4 SAMPLE..doc
Ch 4 SAMPLE..doc
 
Ch 3 DATA.doc
Ch 3 DATA.docCh 3 DATA.doc
Ch 3 DATA.doc
 
Ch 2 Variables.doc
Ch 2 Variables.docCh 2 Variables.doc
Ch 2 Variables.doc
 
Ch 1 Introduction..doc
Ch 1 Introduction..docCh 1 Introduction..doc
Ch 1 Introduction..doc
 
ch 18 roc.doc
ch 18  roc.docch 18  roc.doc
ch 18 roc.doc
 
ch 2 hypothesis
ch 2 hypothesisch 2 hypothesis
ch 2 hypothesis
 
Questionnaire Design
Questionnaire Design Questionnaire Design
Questionnaire Design
 
Research
 Research  Research
Research
 
Study design
Study design Study design
Study design
 
Biotechnology and Genetic Engineering
Biotechnology and Genetic EngineeringBiotechnology and Genetic Engineering
Biotechnology and Genetic Engineering
 

Recently uploaded

Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
Innovative Methods in Media and Communication Research by Sebastian Kubitschk...Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
correoyaya
 
Ch03-Managing the Object-Oriented Information Systems Project a.pdf
Ch03-Managing the Object-Oriented Information Systems Project a.pdfCh03-Managing the Object-Oriented Information Systems Project a.pdf
Ch03-Managing the Object-Oriented Information Systems Project a.pdf
haila53
 
Adjusting primitives for graph : SHORT REPORT / NOTES
Adjusting primitives for graph : SHORT REPORT / NOTESAdjusting primitives for graph : SHORT REPORT / NOTES
Adjusting primitives for graph : SHORT REPORT / NOTES
Subhajit Sahu
 
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
Subhajit Sahu
 
FP Growth Algorithm and its Applications
FP Growth Algorithm and its ApplicationsFP Growth Algorithm and its Applications
FP Growth Algorithm and its Applications
MaleehaSheikh2
 
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
ewymefz
 
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
axoqas
 
Q1’2024 Update: MYCI’s Leap Year Rebound
Q1’2024 Update: MYCI’s Leap Year ReboundQ1’2024 Update: MYCI’s Leap Year Rebound
Q1’2024 Update: MYCI’s Leap Year Rebound
Oppotus
 
一比一原版(YU毕业证)约克大学毕业证成绩单
一比一原版(YU毕业证)约克大学毕业证成绩单一比一原版(YU毕业证)约克大学毕业证成绩单
一比一原版(YU毕业证)约克大学毕业证成绩单
enxupq
 
Business update Q1 2024 Lar España Real Estate SOCIMI
Business update Q1 2024 Lar España Real Estate SOCIMIBusiness update Q1 2024 Lar España Real Estate SOCIMI
Business update Q1 2024 Lar España Real Estate SOCIMI
AlejandraGmez176757
 
Investigate & Recover / StarCompliance.io / Crypto_Crimes
Investigate & Recover / StarCompliance.io / Crypto_CrimesInvestigate & Recover / StarCompliance.io / Crypto_Crimes
Investigate & Recover / StarCompliance.io / Crypto_Crimes
StarCompliance.io
 
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
NABLAS株式会社
 
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
vcaxypu
 
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
axoqas
 
Criminal IP - Threat Hunting Webinar.pdf
Criminal IP - Threat Hunting Webinar.pdfCriminal IP - Threat Hunting Webinar.pdf
Criminal IP - Threat Hunting Webinar.pdf
Criminal IP
 
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdfSample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
Linda486226
 
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
nscud
 
社内勉強会資料_LLM Agents                              .
社内勉強会資料_LLM Agents                              .社内勉強会資料_LLM Agents                              .
社内勉強会資料_LLM Agents                              .
NABLAS株式会社
 
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
John Andrews
 
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
nscud
 

Recently uploaded (20)

Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
Innovative Methods in Media and Communication Research by Sebastian Kubitschk...Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
Innovative Methods in Media and Communication Research by Sebastian Kubitschk...
 
Ch03-Managing the Object-Oriented Information Systems Project a.pdf
Ch03-Managing the Object-Oriented Information Systems Project a.pdfCh03-Managing the Object-Oriented Information Systems Project a.pdf
Ch03-Managing the Object-Oriented Information Systems Project a.pdf
 
Adjusting primitives for graph : SHORT REPORT / NOTES
Adjusting primitives for graph : SHORT REPORT / NOTESAdjusting primitives for graph : SHORT REPORT / NOTES
Adjusting primitives for graph : SHORT REPORT / NOTES
 
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
Algorithmic optimizations for Dynamic Levelwise PageRank (from STICD) : SHORT...
 
FP Growth Algorithm and its Applications
FP Growth Algorithm and its ApplicationsFP Growth Algorithm and its Applications
FP Growth Algorithm and its Applications
 
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
一比一原版(IIT毕业证)伊利诺伊理工大学毕业证成绩单
 
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
做(mqu毕业证书)麦考瑞大学毕业证硕士文凭证书学费发票原版一模一样
 
Q1’2024 Update: MYCI’s Leap Year Rebound
Q1’2024 Update: MYCI’s Leap Year ReboundQ1’2024 Update: MYCI’s Leap Year Rebound
Q1’2024 Update: MYCI’s Leap Year Rebound
 
一比一原版(YU毕业证)约克大学毕业证成绩单
一比一原版(YU毕业证)约克大学毕业证成绩单一比一原版(YU毕业证)约克大学毕业证成绩单
一比一原版(YU毕业证)约克大学毕业证成绩单
 
Business update Q1 2024 Lar España Real Estate SOCIMI
Business update Q1 2024 Lar España Real Estate SOCIMIBusiness update Q1 2024 Lar España Real Estate SOCIMI
Business update Q1 2024 Lar España Real Estate SOCIMI
 
Investigate & Recover / StarCompliance.io / Crypto_Crimes
Investigate & Recover / StarCompliance.io / Crypto_CrimesInvestigate & Recover / StarCompliance.io / Crypto_Crimes
Investigate & Recover / StarCompliance.io / Crypto_Crimes
 
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
【社内勉強会資料_Octo: An Open-Source Generalist Robot Policy】
 
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
一比一原版(ArtEZ毕业证)ArtEZ艺术学院毕业证成绩单
 
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
哪里卖(usq毕业证书)南昆士兰大学毕业证研究生文凭证书托福证书原版一模一样
 
Criminal IP - Threat Hunting Webinar.pdf
Criminal IP - Threat Hunting Webinar.pdfCriminal IP - Threat Hunting Webinar.pdf
Criminal IP - Threat Hunting Webinar.pdf
 
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdfSample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
Sample_Global Non-invasive Prenatal Testing (NIPT) Market, 2019-2030.pdf
 
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
一比一原版(CBU毕业证)卡普顿大学毕业证成绩单
 
社内勉強会資料_LLM Agents                              .
社内勉強会資料_LLM Agents                              .社内勉強会資料_LLM Agents                              .
社内勉強会資料_LLM Agents                              .
 
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
Chatty Kathy - UNC Bootcamp Final Project Presentation - Final Version - 5.23...
 
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
一比一原版(CBU毕业证)不列颠海角大学毕业证成绩单
 

Ch 14 diagn test.doc

  • 1. 14 Describing the Performance of a Diagnostic Test [Q: Write shorts notes on: Performance of diagnostic test (BSMMU, January, 2009)] Types of diagnostic tests 1. Qualitative diagnostic tests classify patients as diseased or disease-free according to the presence or absence of a clinical sign or symptom. For example, an x-ray might confirm or disprove the existence of a fracture. 2. Quantitative diagnostic tests classify patients as diseased or disease-free on the basis of whether they fall above or
  • 2. Biostatistics-139 below a reselected cutoff value known as the positivity criterion. This cutoff value is also referred to as the critical value or referent value. Test performance characteristics [Q:  Define 'specify' and 'sensitivity' with example. (BSMMU, Radiology, January, 2012)  What do you mean by "sensitively" and "specificity". Give example for each of them. (BSMMU, July, 2010)  Discuss the statistical tools used to assess the performance of a diagnosis test. (BSMMU, January, 2011)] 1. Sensitivity Definition: Chance of having a positive test in patients with the test condition Calculating sensitivity: Sensitivity is calculated as the proportion of diseased individuals with a positive test result, using the formula diseased with positive test sensitivity = all diseased Example: Of the 600 individuals with breast cancer as determined by biopsy 570 had a positive result on the BCPF test. Thus, sensitivity = = 570/600 = .95 A high sensitivity implies few false negatives which is important for very rare or lethal diseases, e.g. phenylketonuria. 2. Specificity
  • 3. Biostatistics-140 Definition. Chance of having a negative test in patients without the condition Calculating specificity: Specificity is calculated as the proportion of disease-free individuals with a negative test result, using the formula disease-free with negative test specificity = all disease-free Example: Of the 1000 individuals without breast cancer as determined by biopsy 850 had a negative result on the BCPF test. Thus, specificity = 850/1000 = .85 A high specificity implies few false positives, which is important for common diseases, e.g. diabetes. 3. False negative rate a. Definition. The false negative rate (FNR) of a diagnostic test is the probability that a diseased individual will have a negative test result. c. Calculation. FNR is calculated as the proportion of diseased individuals with a negative test result, using the formula diseased with negative test all diseased FNR= 4. False positive rate a. Definition: The false positive rate(FPR) of a diagnostic test is the probability that a diseases free individual will have a positive result.
  • 4. Biostatistics-141 Calculation: FPR is the calculated as the proportion of diseases free individual with a positive result using the formula diseases free with a positive test all disease free FPR= Example: Of the 1000 individuals who did not have breast cancer , 150 had positive result on the BCPF test, thus FPR=150/1000=1.5 5. Predictive value This is the proportion of positive test results that are truly positive. True positive (a) x 100 True positive (a) + false positive (b) Accuracy The proportion of all tests those are correct. The accuracy of a laboratory test is its correspondence with the true value. An inaccurate test is one that differs from the true value even though the results may be reproducible. In the clinical laboratory, accuracy of tests is maximized by calibrating laboratory equipment with reference material and by participation in external quality control programs. Precision Test precision is a measure of a test’s reproducibility when repeated on the same sample. An imprecise test is one that yields widely varying results on repeated measurements. Validity The extent to which a test measures what it is supposed to measure. Sensitivity and specificity are two important components of validity.
  • 5. Biostatistics-142 Reliability The extent to which a test yields consistent results and thus is replicable Comparison of a survey test with a reference test Table: Comparison of a survey test with a reference test Survey test result Reference test result Totals Positive Negative Positive True positives, correctly identified = (a) False positives = (b) Total test positives = (a + b) Negative False negatives = (c) True negatives correctly identified = (d) Total test negatives = (c + d) Totals Total true positives = (a + c) Total true negatives = (b + d) Grand total = (a + b + c + Valid and reliable
  • 6. Biostatistics-143 d) From this table four important statistics can be derived: Sensitivity = a/ (a + c). Specificity = d/ (b + d). Accuracy = (a+d)/(a+b+c+d) Likelihood ratio The likelihood ratio for a particular value of a diagnostic test is defined as: the probability of that test result in the presence of a disease, divided by the probability of the result in people without the disease. Likelihood ratios express how many times more (or less) likely a test result is to be found in diseased as compared to non- diseased people. Reproducibility It is the variability of repeated measurements under different conditions. [Q:  Out of 1000 suspected lung cancer patients, 800 found to have the disease diagnosed by CT scan. Among those, 320 patients were found FNAC positive and the total FNAC positive were 322. Evaluate the performance of FNAC in the diagnosis of lung cancer. (BSMMU, Radiology, January, 2012)  USG negative cases respectively. Will you advocate USG for diagnosis of hepatoma? (BSMMU, July, 2011)  1000 suspected brain tumor patients were subjected to CT scan & MRI. Based on MRI 200 diagnosed as brain tumor of which 156 were CT positive out of total 420 CT Positive cases. Evaluate the performance of CT scan of diagnosis of brain tumor. (BSMMU, January, 2011)  317 suspected cases of heptoma were subjected to FNAC and CT scan. FNAC confirmed hepatoma in 113 and 08 cases out of 128 CT positive & 189 CT negative cases respectively. Evaluate the performance of CT scan in diagnosis of hepatoma. (BSMMU, July, 2010)
  • 7. Biostatistics-144  370 suspected cases of prostate cancer were investigated by CT scan and serum PSA. CT scan confirmed prostate cancer in 113 and 8 cases out of 8 cases out of 178 PSA positive and 192 PSA negative cases receptivity. Will you advocate PSA measurement in diagnosis of prostate cancer? (BSMMU, January, 2009)]